FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

430242005: Regadenoson (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2708658015 Regadenoson (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2765897017 Regadenoson en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
365471000195114 regadenoson it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
367451000077111 regadenoson fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
837711000172119 régadénoson fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3339351001000115 Regadenoson de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regadenoson (substance) Is a Adenosine A2 receptor agonist true Inferred relationship Some
Regadenoson (substance) Is a Pyrazole derivative true Inferred relationship Some
Regadenoson (substance) Is a Purine nucleoside true Inferred relationship Some
Regadenoson (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Adenosine A2 receptor agonist (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Regadenoson 0.08mg/mL injection solution 5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Regadenoson (substance) Inferred relationship Some
Regadenoson 0.08mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Regadenoson (substance) Inferred relationship Some
Product containing regadenoson (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regadenoson (substance) Inferred relationship Some 1
Regadenoson only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regadenoson (substance) Inferred relationship Some 1
Product containing precisely regadenoson 80 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Regadenoson (substance) Inferred relationship Some 1
Product containing precisely regadenoson 80 microgram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Regadenoson (substance) Inferred relationship Some 1
Regadenoson-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regadenoson (substance) Inferred relationship Some 1
Product containing only regadenoson in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regadenoson (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start